Verily

Lore & Background

On 9 September 2014, the then-Google X division Google Life Sciences acquired Lift Labs, the makers of Liftware. On August 10, 2015, Sergey Brin announced that the organization would become an independent subsidiary of Alphabet Inc. On December 7, 2015, Google Life Sciences was renamed Verily. Verily Life Sciences in January 2019 raised $1 billion in funding. At the end of 2019, Verily sold its stake in robot-assisted surgery joint venture Verb Surgical to development partner Johnson & Johnson. In August 2020, Verily announced that it is entering into the insurance market with the launch of Coefficient Insurance Company. In August 2021, Verily acquired SignalPath. In October 2022, the first patient was screened for diabetic retinopathy at the Baton Rouge Clinic using Verily Retinal Service. In September 2022, Verily announced longtime CEO Andy Conrad would step down as CEO in January 2023, to be replaced by Stephen Gillett who became CEO on January 3, 2023. In January 2023, fifteen percent of Verily's workforce was laid off as part of a broader restructuring by parent company, Alphabet. In October 2023, the Centers for Disease Control and Prevention selected Verily to support the agency's National Wastewater Surveillance System. In June 2024, Verily decided to close its operations in Israel three years after opening a research and development center in the country. In August 2024, Verily moved its headquarters from South San Francisco to Dallas. In September 2024, Verily expanded its wastewater testing services to Europe through a partnership with Bangor University in Wales. In October 2024, a Verily-led data and technology consortium received a $4.8M award from the National Institutes of Health. In January 2025, Verily signed an agreement to sell its stop-loss insurance unit, Granular (formerly known as Coefficient), to Elevance.

Reader's Guide

Verily is a life sciences research organization under Alphabet Inc. It was formerly a division of Google X and became a standalone company under Alphabet as of December 2024. Its projects include the Dexcom G7 continuous glucose monitors, Galvani Bioelectronics, Verb Surgical, Lift Labs spoon, the Baseline Study, Onduo, and Study Watch. Discontinued projects include contact lenses for glucose monitoring, smart shoes, skin research with L’Oréal, and a disease-detecting nanoparticle platform called Tricorder.

Did You Know?

• Verily was originally called Google Life Sciences before being renamed on December 7, 2015.
• In August 2020, Verily entered the insurance market with the launch of Coefficient Insurance Company.
• Verily moved its headquarters from South San Francisco to Dallas in August 2024.
• In January 2025, Verily agreed to sell its stop-loss insurance unit Granular to Elevance.